SYN - Synthetic Biologics, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
-
-
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
11,212
11,844
18,784
29,109
32,906
Selling General and Administrative
4,499
5,727
7,467
10,143
8,074
Total Operating Expenses
15,711
17,571
26,251
39,252
40,980
Operating Income or Loss
-15,711
-17,571
-26,251
-39,252
-40,980
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
4,083
10,738
11,412
-3,811
Income Before Tax
-15,428
-13,421
-15,492
-27,803
-44,785
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-15,428
-13,421
-15,492
-27,803
-44,785
Net Income
-15,336
-13,367
-15,174
-27,255
-43,737
Net Income available to common shareholders
-27,850
-25,291
-22,136
-27,255
-43,737
Reported EPS
Basic
-
-4.06
-6.30
-10.15
-18.90
Diluted
-
-4.06
-6.30
-10.15
-18.90
Weighted average shares outstanding
Basic
-
6,232
3,553
2,694
2,306
Diluted
-
6,232
3,553
2,694
2,306
EBITDA
-
-17,299
-26,006
-39,095
-40,908